Letters Medicines funding

Value for money is nothing new

BMJ 2007; 335 doi: https://doi.org/10.1136/bmj.39296.765903.3A (Published 16 August 2007) Cite this as: BMJ 2007;335:318
  1. Matthew Brougham, acting chief executive
  1. PHARMAC, PO Box 10 254, Wellington 6143, New Zealand
  1. matthew.brougham{at}pharmac.govt.nz

    Pursuing value for money in medicines funding is neither tough nor new.1

    PHARMAC (New Zealand's funder) has focused strongly on it for 14 years. We are mindful of funding trade-offs through …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe